Response to anti-cancer drugs linked to your genes

Published On 2015-09-14 05:56 GMT | Update On 2015-09-14 05:56 GMT

An international study has recently announced its findings on anti-cancer drugs and, its response to your body. A person’s response to anti-cancer drug treatments is strongly related to his or her genetic ancestry, says new research.The findings suggest that the same medicine can affect people from different ethnicities differently.

“Based on the cell lines of hundreds of individuals, our research suggests that the genetic ancestry of a person is strongly related to a person’s response to anticancer drug treatment,” said lead study author John Jack, research scientist at North Carolina State University in the US.

The researchers examined the role of ethnicity in drug potency and efficacy for 28 chemotherapeutic compounds in 589 patients. Patients self-reported their ethnicity as Hispanic or non-Hispanic/Caucasian.

Hispanic and Caucasian samples exhibited unique results, indicating a complex relationship between genome and drug response and treatment outcomes, the study said. Notable associations were found for the drug temozolomide which is used to treat brain tumours.

Other drugs with results that suggest an association include etoposide and mitomycin, the team noted. “The developing field of ‘personalised’ or ‘precision medicine’ will leverage these types of data to help inform a doctor’s decision on selecting the optimal drug and dose for each patient,” Mr. Jack said.

The study was published in the journal Pharmacogenomics.

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Meghna A Singhania is the founder and Editor-in-Chief at Medical Dialogues. An Economics graduate from Delhi University and a post graduate from London School of Economics and Political Science, her key research interest lies in health economics, and policy making in health and medical sector in the country. She is a member of the Association of Healthcare Journalists. She can be contacted at meghna@medicaldialogues.in. Contact no. 011-43720751

Comments Policy

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Response to anti-cancer drugs linked to your genes

Similar News

Swasth Nari Sashakt Parivar Abhiyaan concludes, benefits over 6.5 crore women

Jharkhand HC directs Govt to frame HIV guidelines for prison inmates

Bhopal Gas Tragedy: SC issues contempt notices to Health Ministry, ICMR over non-compliance of orders on medical care

Chhattisgarh NHM employees end strike after Government Talks

India conferred with Bloomberg Philanthropies Global Tobacco Control Award

LIC eyes entry into health insurance space by month end

Meerut doctor, 3 Touts arrested for illegal sex determination test

RG Kar Financial Irregularities Case: Court Reprimands CBI for Failing to Provide Documents